Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization

Figure 3 Radiological response according to presence of sarcopenia. A: Complete response vs partial response vs stable disease vs progressive disease assessed using the mRECIST criteria after the first session of treatment; B: Complete and partial response and stable disease vs progressive disease assessed using the mRECIST criteria after the first session of treatment. Statistical analysis was performed using the chi square test. CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progressive disease; TACE: Trans-arterial chemoembolization.